2025
Accounting for unmet needs resulting from cancer-related cognitive impairment
Haywood D, Chan A, Chan R, Dauer E, Dhillon H, Henneghan A, Lustberg M, O’Connor M, Vardy J, Rossell S, Hart N. Accounting for unmet needs resulting from cancer-related cognitive impairment. Journal Of Cancer Survivorship 2025, 1-11. PMID: 40067418, DOI: 10.1007/s11764-025-01769-6.Peer-Reviewed Original ResearchCancer-related cognitive impairmentPsychological distressUnmet needsCancer survivorsImpairment severityStages of cancerCognitive impairmentCancer SurvivorsThe resultsPurposeCancer-related cognitive impairmentPerceived cognitive impairmentCare targetsCognitive impairment severityDASS-21Descriptive statisticsMultiple regression analysisPsychological factorsDistressClinical questionsBivariate correlationsSupportive careRegression analysisNeedsSurvivorsImpairmentPredictive utility
2024
Global retrospective study comparing consolidation ALK tyrosine kinase inhibitors (TKI) to durvalumab (durva) or observation (obs) after chemoradiation (CRT) in unresectable locally-advanced ALK+ non-small cell lung cancer (NSCLC).
Jayakrishnan R, Nassar A, Shepherd F, Lin J, Lin S, Shakya P, Dilling T, Bar J, Grohe C, Gupta S, Fitzgerald B, Adib E, Sankar K, Neal J, Yu H, Whitaker R, Velazquez Manana A, Naqash A, Goldberg S, Kim S. Global retrospective study comparing consolidation ALK tyrosine kinase inhibitors (TKI) to durvalumab (durva) or observation (obs) after chemoradiation (CRT) in unresectable locally-advanced ALK+ non-small cell lung cancer (NSCLC). Journal Of Clinical Oncology 2024, 42: 8013-8013. DOI: 10.1200/jco.2024.42.16_suppl.8013.Peer-Reviewed Original ResearchALK+ non-small cell lung cancerALK tyrosine kinase inhibitorsNon-small cell lung cancerTreatment-related adverse eventsTyrosine kinase inhibitorsPD-L1 statusOverall survivalConcurrent chemoradiationPD-L1Retrospective studyTreatment discontinuation due to toxicityLocally-advanced non-small cell lung cancerDiscontinued due to toxicityMultivariate Cox regression modelEfficacy of alectinibInternational retrospective analysisOptimal consolidation therapyProgression-free survivalCell lung cancerCox regression modelsBaseline characteristics of ageStandard of careMedian OSStages of cancerConsolidation therapy
2007
Analysis of matched case–control data with multiple ordered disease states: possible choices and comparisons
Mukherjee B, Liu I, Sinha S. Analysis of matched case–control data with multiple ordered disease states: possible choices and comparisons. Statistics In Medicine 2007, 26: 3240-3257. PMID: 17206600, DOI: 10.1002/sim.2790.Peer-Reviewed Original ResearchConceptsConditional logistic regressionStratum-specific nuisance parametersCase-control dataAdjacent-category logit modelCase-control studyOrdered categorical dataConditional-likelihood approachLikelihood-based approachNuisance parametersProportional-odds modelCumulative logitsSimulation studyAnalyse such dataMantel-Haenszel approachCumulative logit modelNatural orderPotential risk factorsStages of cancerReference categoryCategorical dataLogistic regressionOrdinal natureEffect of potential risk factorsLow birthweightRisk factors
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply